ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced results of its latest industry survey, examining the challenges clinical trial sites face during study startup.
Applied Clinical Trials Online

New ICON Survey Shows Sites Face Growing Delays and Communication Gaps During Study Startup

ICON’s June 2025 survey of more than 100 investigators and site leaders reveals persistent bottlenecks in study startup driven by contract and budget delays, slow activation timelines, and ...
Insider Monkey

ICON plc (ICLR): Revolutionizing Clinical Trials with AI Innovations

We recently published a list of 10 AI News and Ratings Too Important to Miss. In this article, we are going to take a look at where ICON Public Limited Company (NASDAQ:ICLR) stands against other AI ...
Insider Monkey

ICON Public Limited Company (ICLR) Leverages AI-Powered Medidata Platform to Optimize Clinical Trials

We recently compiled a list of the Top 8 Trending AI Stock Updates On Wall Street Today. In this article, we are going to take a look at where ICON Public Limited Company (NASDAQ:ICLR) stands against ...
Nasdaq

ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report

DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research ...
Business Wire

ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business ...
Business Wire

ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2024 with a number of leading ...
PharmiWeb

Clinical Trials Market Insights: Industry Opportunities, Drivers, Outlook and Trends Research Report

The global clinical trials market is anticipated to grow at a CAGR of 6-7% from 2024 to 2029. This growth is driven by the ...
Nasdaq

ICON plc to Present at Upcoming Investor Conferences

DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will ...

ICON plc to Present at Jefferies London Healthcare Conference

On November 12, 2025, ICON plc announced that its CEO, Barry Balfe, and CFO, Nigel Clerkin, will present at the Jefferies London Healthcare Conference on November 19, 2025. This participation ...
Hosted on MSN

Should You Hold ICON PLC (ICLR)?

Wasatch Global Investors, an asset management company, released its “Wasatch U.S. Select Strategy” first-quarter 2025 investor letter. A copy of the letter can be downloaded here. US equities declined ...